CPA VIETNAM AUDITING COMPANY LIMITED
Qualified services, global understanding and vision

Cooperation with Japan to standardize cell production facilities in Vietnam

10/11/2026 - 09:20      18 view
Through collaboration with CM Plus Corporation (Japan), Mescells|MSC aims to standardize cell production facilities in Hanoi according to Japanese standards, gradually enhancing quality management capabilities, research, and development of cell technology in the field of regenerative medicine.
Nội dung chính[ẩn][hiện]

Cooperation with Japan to standardize cell production facilities in Vietnam

The Memorandum of Understanding (MOU) between Mescells|MSC and CM Plus Corporation is exchanged on November 9 under the witness of the top Vietnamese leader and senior leaders of both countries. (Photo: VNA)

 Within the framework of the Vietnam-Japan Public-Private Forum on Economic, Scientific and Technological Cooperation, held in Tokyo on November 9 as part of the official visit to Japan by Party General Secretary and President To Lam of Vietnam,   the Mescells|MSC Specialized Healthcare System for Regenerative Medicine & Cell Therapy of Vietnam and CM Plus Corporation of Japan signed a Memorandum of Understanding (MOU),  under the witness of the top Vietnamese leader and  senior leaders of both countries.

The agreement aims to promote professional cooperation, transfer management experience, and standardize cell production facilities (Cell Processing Center – CPC) in Vietnam according to the standards and technical requirements applied in Japan.

According to the agreement, CM Plus Corporation will provide professional consulting services, supporting Mescells|MSC in the process of standardizing and registering the recognition of cell production facilities in Hanoi according to Japanese standards and requirements for the Cell Processing Center (CPC).

The focus of the cooperation is to meet the requirements set by the Ministry of Health, Labor and Welfare of Japan (MHLW), through the establishment of a quality management system (QMS), completion of operational procedures, facility conditions, and technical requirements in cell processing and production activities.

These are crucial factors to ensure that cell production activities are controlled according to professional procedures and quality requirements.

CM Plus Corporation is a Japanese enterprise operating in the field of quality management consulting, regulatory compliance, project management, and construction of production facilities in the life sciences sectors, particularly pharmaceuticals, medical devices, and regenerative medicine.

The company has experience in consulting on quality management systems, GMP/GDP, GCTP standards, GAP assessments, facility validation, and professional training. In the field of regenerative medicine, CM Plus participates in planning, constructing, and standardizing Cell Processing Centers.

In Vietnam, CM Plus established a subsidiary in 2013, implementing consulting, training, and cooperation connection activities.

Through this cooperation, Mescells|MSC aims to access Japanese management experience, quality control, and technical processes, gradually improving the operational capacity of cell production facilities in Hanoi.

Moreover, through collaboration with CM Plus Corporation, Mescells|MSC aims to standardize cell production facilities in Hanoi according to Japanese standards, gradually enhancing quality management capabilities, research, and development of cell technology in the field of regenerative medicine.

Mescells|MSC is a healthcare system operating in the fields of research, training, production, and application of cell technology and regenerative medicine.

Within this system, the Mescells Institute of Applied Cell Technology Research is licensed by the Vietnamese Ministry of Science and Technology to research cell technology and therapies in regenerative medicine. The institute  is also licensed by the Department of Science, Technology and Training under the Vietnamese Ministry of Health to train doctors and medical staff in stem cell technology.

Additionally, the Mescells Tissue Bank is licensed by the Ministry of Health to operate with functions of receiving, preserving, storing, and transporting adipose tissue and umbilical cord tissue.

Based on research, training, and tissue storage activities, Mescells|MSC aims to develop cell production facilities according to international standards, gradually completing the chain of activities from research to production and application of cell technology.

16/11/2026 7
Continuing the agenda of the National Assembly's second session on November 12, lawmakers held a question-and-answer session focusing on the science and technology sector.
View details
16/11/2026 8
As a pioneering public-private co-investment model in Vietnam, the program combines international capital with domestic resources.
View details
16/11/2026 8
The 2025 state budget deficit accounts for only 3.1% of GDP, significantly lower than the projected 3.8%.
View details
13/11/2026 20
A new draft decree will refine Vietnam's carbon market framework, introducing quota allocation and auction mechanisms alongside national credit standards.
View details
13/11/2026 22
The Government has been rolling out multiple programs to strengthen domestic corporate capacity, starting with continued institutional reform.
View details
13/11/2026 20
By the end of 2025, e-commerce sales are estimated to reach approximately $37 billion, making Vietnam the country with the second-fastest e-commerce growth rate in Southeast Asia.
View details
12/11/2026 20
As Vietnam builds its international financial centers in Ho Chi Minh City and Da Nang, financial resources, governance expertise, and technology from the UK are set to act as a vital link driving global capital into the real economy.
View details
12/11/2026 22
Amazon Web Services (AWS) has launched the AWS Health Impact Initiative (HII), committing $100 million over five years to support healthcare organizations globally, including in Vietnam, in leveraging artificial intelligence and cloud computing for underserved communities.
View details
12/11/2026 17
The new Law on Petroleum 2026 aims to translate expectations for the oil and gas industry into tangible outcomes.
View details
11/11/2026 21
Vietnam’s new era of development and ambitious growth targets require that the oil and gas industry evolve from its role as a traditional growth pillar.
View details
11/11/2026 30
Under Decision No. 2946/QD-BCT, the framework applies to solar power plants specified in Circular No. 09/2025/TT-BCT and divides the country into three pricing regions: Northern, Central, and Southern Vietnam.
View details
11/11/2026 49
Total funding reaching nearly VND500 billion ($19 million).
View details
Head Office
Representative Office
Northern Branch
Ho Chi Minh City Branch
Key thời gian làm việc
Copyright © 2026 CPA VIETNAM AUDIT. All rights reserved. Website designed by Tat Thanh
Access statistics
Total visits: 487958 Currently visiting: 325
Website Policy